New AppliedXL partners with Kalshi to bring verifiable resolution infrastructure to biopharma prediction markets Read the announcement

The biotech record, before it’s news.

AppliedXL turns the public biopharma record into decisions. Every trial, filing, and readout, scored and structured, so you see what’s coming while it’s still forming.

The AppliedXL Biotech platform — Discover feed with live readouts and Probability of Success scoring
Trusted by

What the data says about any program

Live estimates that move as the data moves, not a static number in a slide. 88% directional accuracy. How it works →

Enrollment stalls, site changes, protocol amendments: the operational signals that shift a timeline before the estimate catches up.

A program’s whole arc, first patient to primary completion, updating as it runs.

Every asset, every player, current

An entire indication, target, portfolio in one view. Save what you follow, pick up where you left off.

Who else is in the race, where they stand, and what their readout means for yours.

Every readout and decision date on one horizon. Know what’s on the clock.

A record with receipts

Every snapshot preserved for 5 years. No survivorship bias, no rewritten history. Backtest against what was known, when it was known.

Pin a program. When its status moves, you know within a minute.

Ask the record a question in plain language. Grounded in the structured record, it answers where domain-agnostic models guess. See the benchmark →

Start with the record.

Every trial, filing, and readout — scored, structured, and moving in real time.